BioCancell Therapeutics Inc. is a biotechnology company specializing in the development of Patient-Oriented, Targeted Therapy for the treatment of a wide range of cancers. Its therapeutic and diagnostic technology constitutes a novel ‘search and destroy’ paradigm for the targeted destruction of cancer cells – with no effect on surrounding tissue and no observed side effects – for long-term, safe treatment and prevention of cancer.
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 01/01/08 | Series A | 2.5M | Unknown |
People
Avi Barak (CEO)
Avraham Hochberg (CSO, Co-Founder)
Ira Weinstein (CFO, COO)
Avraham Hochberg (Board Member)
Avi Barak (Board Member)
View more details about all 6 people at BioCancell Therapeutics
Competitors
On-Q-Ity:
Informed decisions will improve the way cancer is treated. On-Q-ity is an innovative diagnostic company that… See Company Profile »